Drug Information

Drug General Information
Drug ID
D00XMO
Former ID
DNC009753
Drug Name
2-(4-chlorobenzylidene)cyclopentyl ethyl ether
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529980]
Formula
C14H17ClO
Canonical SMILES
CCOC1CCCC1=CC2=CC=C(C=C2)Cl
InChI
1S/C14H17ClO/c1-2-16-14-5-3-4-12(14)10-11-6-8-13(15)9-7-11/h6-10,14H,2-5H2,1H3/b12-10+
InChIKey
VORGMCXCJIDOMV-ZRDIBKRKSA-N
PubChem Compound ID
44126813
Target and Pathway
Target(s) Aldo-keto reductase family 1 member C3 Target Info Inhibitor [529980]
BioCyc Pathway Superpathway of steroid hormone biosynthesis
Allopregnanolone biosynthesis
Androgen biosynthesis
KEGG Pathway Steroid hormone biosynthesis
Arachidonic acid metabolism
Metabolic pathways
Ovarian steroidogenesis
NetPath Pathway TGF_beta_Receptor Signaling Pathway
PathWhiz Pathway Arachidonic Acid Metabolism
Reactome Retinoid metabolism and transport
WikiPathways Metapathway biotransformation
Benzo(a)pyrene metabolism
Arachidonic acid metabolism
References
Ref 529980Eur J Med Chem. 2009 Jun;44(6):2563-71. Epub 2009 Feb 5.New cyclopentane derivatives as inhibitors of steroid metabolizing enzymes AKR1C1 and AKR1C3.
Ref 529980Eur J Med Chem. 2009 Jun;44(6):2563-71. Epub 2009 Feb 5.New cyclopentane derivatives as inhibitors of steroid metabolizing enzymes AKR1C1 and AKR1C3.